Addiction Medicine Journal Club: Recent Episodes
Sonya Del Tredici and John Keenan
We believe that addiction is a disease that can be treated, and we want to help you stay up to date with the latest research that you can use in your addiction medicine practice.
In episode 28 we discuss an article about pain and addiction recovery.
Ajay Manhapra, Elina A. Stefanovics, Taeho Greg Rhee, Robert A. Rosenheck, Persistence of significant pain interference following substance use disorder remission: Negative association with psychosocial and physical recovery, Drug and Alcohol Dependence, Volume 232, 2022, 109339, ISSN 0376-8716,
We also discuss top-selling flavored e-cigarette products, and Sweden becoming the first smoke-free country.
Scripps News: Sweden Close to Becoming the Frist Smoke-Free Country in Europe
JAMA Network Open: Evaluation of statewide restrictions on flavored e-cigarette sales in the US from 2014 to 2020
CDC: E-cigarette Unit Sales by Product and Flavor Type, and Top-Selling Brands, United States, 2020–2022
One of our listeners sent us this article too: Mortality Among Homeless Adults in Boston: Shifts in Causes of Death Over a 15-year Period.
This episode is eligible for CME credit from MICARES and Michigan State University. Go to www.micaresed.org to make an account. Take a brief quiz and get your credit here.
Episode 28 Credits:
Original theme music: composed and performed by Benjamin Kennedy
Audio production: Erin McCue
Executive Producer: Dr. Patrick Beeman
A podcast from Ars Longa Media
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on Twitter, Facebook, YouTube, Spotify, email, or join our Facebook group.
Email: addictionmedicinejournalclub@gmail.com
Twitter: @AddictionMedJC
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
YouTube: addictionmedicinejournalclub
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
- The First Opioid Prescription
In episode 27 we discuss an article about the risk of developing opioid use disorder after the first opioid prescription.
Kendler, K., Lönn, S., Ektor-Andersen, J., Sundquist, J., & Sundquist, K. (2022). Risk factors for the development of opioid use disorder after first opioid prescription: A Swedish national study. Psychological Medicine, 1-9. doi:10.1017/S003329172200349X
From JAMA: Physicians’ actions to help end the nation’s drug-related overdose and death epidemic—and what still needs to be done.
This episode is eligible for CME credit from MICARES and Michigan State University. Go to www.micaresed.org to make an account. Take a brief quiz and get your credit here.
Episode 27 Credits: Original theme music: composed and performed by Benjamin Kennedy Audio production: Erin McCue Executive Producer: Dr. Patrick Beeman A podcast from Ars Longa Media
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on Twitter, Facebook, YouTube, Spotify, email, or join our Facebook group.
Email: addictionmedicinejournalclub@gmail.com Twitter: @AddictionMedJC Facebook: @AddictionMedJC Facebook Group: Addiction Medicine Journal Club YouTube: addictionmedicinejournalclub
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
- Addiction Survivors
In episode 26 we discuss a new conceptual model of addiction recovery.
Pytell, J.D., Chander, G., Thakrar, A.P. et al. Pytell, J.D., Chander, G., Thakrar, A.P. et al. Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment. J GEN INTERN MED 38, 1638–1646 (2023).
We also talk about choosing wisely in addiction medicine. What would be on your “Things we do for no reason” list?
From the Journal of the Society of Hospital Medicine: Avoiding methadone for opioid withdrawal From Choosing Wisely Canada: 8 Tests and Treatments to Question in Addiction Medicine
Episode 26 Credits:
Original theme music: composed and performed by Benjamin Kennedy
Audio production: Erin McCue
Executive Producer: Dr. Partick Beeman
A podcast from Ars Longa Media
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on Twitter, Facebook, YouTube, Spotify, email, or join our Facebook group.
Email: addictionmedicinejournalclub@gmail.com
Twitter: @AddictionMedJC
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
YouTube: addictionmedicinejournalclub
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
- High-dose Buprenorphine Induction
In episode 25 we discuss an article about high-dose buprenorphine induction.
Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128.
From NPR: Drugmaker Mallinckrodt may renege on $1.7 billion opioid settlement
Episode 25 Credits:
Original theme music: composed and performed by Benjamin Kennedy
Audio production: Erin McCue
Executive Producer: Dr. Partick Beeman
A podcast from Ars Longa Media
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on Twitter, Facebook, YouTube, Spotify, email, or join our Facebook group.
Email: addictionmedicinejournalclub@gmail.com
Twitter: @AddictionMedJC
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
YouTube: addictionmedicinejournalclub
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
- We discuss updated data on the harms of smoking and the benefits of quitting.
Thomson B, Emberson J, Lacey B, et al. Association Between Smoking, Smoking Cessation, and Mortality by Race, Ethnicity, and Sex Among US Adults. JAMA Netw Open. 2022;5(10):e2231480. doi:10.1001/jamanetworkopen.2022.31480
We also discuss the drug supply shift from heroin to fentanyl, and how California wants to decriminalize psychedelics.
CDC: Rapid Analysis of Drugs: A Pilot Surveillance System To Detect Changes in the Illicit Drug Supply To Guide Timely Harm Reduction Responses — Eight Syringe Services Programs
From the California Senate: Senator Weiner Reintroduces Legislation to Decriminalize Psychedelics
Episode 24 Credits:
Original theme music: composed and performed by Benjamin Kennedy
Audio production: Erin McCue
Video production: Spencer Kennedy
Executive Producer: Dr. Partick Beeman
A podcast from Ars Longa Media
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on Twitter, Facebook, YouTube, Spotify, email, or join our Facebook group.
Email: addictionmedicinejournalclub@gmail.com
Twitter: @AddictionMedJC
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
YouTube: addictionmedicinejournalclub
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
- We discuss an article about the Eat-Sleep-Console approach to treat neonatal opioid withdrawal syndrome.
Young LW, Ounpraseuth ST, et. al. ACT NOW Collaborative. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal. N Engl J Med. 2023 Apr 30. doi: 10.1056/NEJMoa2214470. Epub ahead of print. PMID: 37125831.
We also share how even nematodes get the endocannabinoid munchies, and semaglutide helps rats with their binge-drinking.
The conserved endocannabinoid anandamide modulates olfactory sensitivity to induce hedonic feeding in C. elegans
Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats
What Ozempic Reveals About Desire
Episode 23 Credits:
Original theme music: composed and performed by Benjamin Kennedy
Audio production: Erin McCue
Video production: Spencer Kennedy
Executive Producer: Dr. Partick Beeman
A podcast from Ars Longa Media
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on Twitter, Facebook, YouTube, Spotify, email, or join our Facebook group.
Email: addictionmedicinejournalclub@gmail.com
Twitter: @AddictionMedJC
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
YouTube: addictionmedicinejournalclub
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
- Contingency Management for Coronary Artery Disease
22: We discuss an article about contingency management and the regression of coronary plaques in HIV+ cocaine users.
Lai, Hong PhD; Bluemke, David A. MD; Fishman, Elliot K. MD; Gerstenblith, Gary MD; Celentano, David D. ScD; Treisman, Glenn MD; Foster, Parker MS; Mandler, Raul MD; Khalsa, Jag MS, PhD; Chen, Shaoguang MS; Bhatia, Sandeepan MD; Kolossváry, Márton MD; Lai, Shenghan MD. High-risk Coronary Plaque Regression in Cash-based Contingency Management Intervention Among Cocaine Users With HIV-associated Subclinical Coronary Atherosclerosis. Journal of Addiction Medicine 17(2):p 147-154, 3/4 2023.
How to understand contingency management, from the Bloomberg school of public health: Contingency Management for Treatment of Stimulant Use Disorder and Strategies to Address Polysubstance Use
We also discuss places to get your new MATE-ACT 8-hour trainings:
Providers Clinical Support System The Curbsiders Addiction Medicine NIDA Courses ASAM E-Learning Courses AMA Opioid Education
Episode 22 Credits:
Original theme music: composed and performed by Benjamin Kennedy
Audio production: Erin McCue
Video production: Spencer Kennedy
Executive Producer: Dr. Partick Beeman
A podcast from Ars Longa Media
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on Twitter, Facebook, YouTube, Spotify, email, or join our Facebook group.
Email: addictionmedicinejournalclub@gmail.com
Twitter: @AddictionMedJC
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
YouTube: addictionmedicinejournalclub
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Short on time? In this episode we give you quick summaries of articles 1-10.
- Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease
- Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder
- Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids
- Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality: A Prospective Cohort Study
- Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial
- Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System
- Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use
- Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial
- Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, send us your comments on Twitter or email, or join our Facebook group to continue the discussion.
- Email: addictionmedicinejournalclub@gmail.com
- Twitter: @AddictionMedJC
- Facebook: @AddictionMedJC
Credits:
- Wordsmithing: Spencer Kennedy
- Original theme music: composed and performed by Benjamin Kennedy
- Audio production: Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
In episode 10 we discuss an article about buprenorphine tapering.Bozinoff N, Men S, Kurdyak P, Selby P, Gomes T. Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper. JAMA Netw Open. 2022;5(9):e2234168. ----------
Take a look at Riggs, KR, DeRussy, AJ, Leisch, L, et al. Sensitivity of health records for self-reported nonfatal drug and alcohol overdose. Am J Addict. 2022; 1- 6**.
We also discuss the federal government’s plan to provide care for people with opioid use disorder during pregnancy. Watch Matthew Perry talk about his new memoir about addiction and recovery with Diane Sawyer.*Resources for safer drug use* from the Harm Reduction Research and Treatment Center.
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, send us your comments on Twitter, Facebook, or email, or join our Facebook group to continue the discussion.**
- Email: addictionmedicinejournalclub@gmail.com
- Twitter: @AddictionMedJC
- Facebook: @AddictionMedJC
Credits:
- Original theme music: composed and performed by Benjamin Kennedy
- Audio production: Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
In episode 9 we discuss psilocybin for treating alcohol use disorder.Bogenschutz MP, Ross S, Bhatt S, et al. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(10):953–962. doi:10.1001/jamapsychiatry.2022.2096 **----------
We talk about Wal-Mart and CVS not filling some telemedicine prescriptions.
We also discuss gabapentin involvement in overdose deaths and the efficacy of gabapentin for neuropathic pain.*Mattson CL, Chowdhury F, Gilson TP.* Notes from the Field: Trends in Gabapentin Detection and Involvement in Drug Overdose Deaths — 23 States and the District of Columbia, 2019–2020. MMWR Morb Mortal Wkly Rep 2022;71:664–666*Wiffen PJ, Derry S, Bell RF, Rice ASC, Tölle TR, Phillips T, Moore RA. Gabapentin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2017, Issue 6. Art. No.: CD007938. DOI: 10.1002/14651858.CD007938.pub4. Accessed 21 October 2022* ----------
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, send us your comments on Twitter or email, or join our Facebook group to continue the discussion.**
- Email: addictionmedicinejournalclub@gmail.com
- Twitter: @AddictionMedJC
- Facebook: @AddictionMedJC
Credits:
- Original theme music: composed and performed by Benjamin Kennedy
- Audio production: Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
In episode 8 we discuss the article about opioid tapering and discontinuation, and the risks of suicide and overdose.Larochelle MR, Lodi S, Yan S, Clothier BA, Goldsmith ES, Bohnert ASB. Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy. JAMA Netw Open. 2022;5(8):e2226523. doi:10.1001/jamanetworkopen.2022.26523 We also discuss the recent Ruan vs. United States supreme court decision **about pill mills.
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, send us your comments on Twitter or email, or join our Facebook group to continue the discussion.**
- Email: addictionmedicinejournalclub@gmail.com
- Twitter: @AddictionMedJC
- Facebook: @AddictionMedJC
Credits:
- Original theme music: Composed and performed by Benjamin Kennedy
- Audio production: Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
In Episode 7 we discuss treating opioid use disorder with co-occurring polysubstance use.
Xu KY, Mintz CM, Presnall N, Bierut LJ, Grucza RA. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use. JAMA Netw Open. 2022;5(5):e2211363. 2022 Aug 3. doi:10.1001/jamanetworkopen.2022.11363
We also discuss the Society of Hospital Medicine’s new consensus statement about management of opioid use disorder in the hospital, and hepatotoxicity from depot buprenorphine.
Calcaterra SL, Et. Al. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. J Hosp Med. 2022 Jul 26.
A free summary of the recommendations is in ACP Hospitalist.
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. In this podcast we review current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, send us your comments.
- Email: addictionmedicinejournalclub@gmail.com
- Twitter: @AddictionMedJC
- Facebook: @AddictionMedJC
Credits:
- Original theme music: composed and performed by Benjamin Kennedy
- Audio production: Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
In episode 6 we discuss a benzodiazepine-sparing alcohol withdrawal protocol.
Smith JT, Sage M, Szeto H, et al. Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System. JAMA Netw Open. 2022;5(2):e220158. 2022 Feb 2. doi:10.1001/jamanetworkopen.2022.0158
We also discuss long-term outcomes from a primary-care based MAT clinic, and the movement to deregulate methadone and expand access.
Cope K, DeMicco J, Salib J, Michael M, Yakoub P, Daoud K, Cope R. Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice. J Addict Med. 2022 Aug 1. doi: 10.1097/ADM.0000000000001009. PMID: 35913992.
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, send us your comments.
- Email: addictionmedicinejournalclub@gmail.com
- Twitter: @AddictionMedJC
- Facebook: @AddictionMedJC
Credits:
- We got help for this episode from the St. Max’s medical librarians.
- Original theme music: composed and performed by Benjamin Kennedy
- Audio production: Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Episode 5 discusses the clinical effects of getting a medical marijuana card.
Gilman JM, Schuster RM, Potter KW, et al. Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(3):e222106.
If you want an introduction on how to manage medical marijuana in primary care, listen to this awesome episode from The Curbsiders.
We also discuss ASAM Connect, and how to get more PCPs into addiction medicine.
If you’re thinking of prescribing buprenorphine in your office, start with the SAMHSA quick-start guide. For a deeper dive, you can read the textbook “Treating Opioid Use Disorder in General Medical Settings.”
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, you can email us at addictionmedicinejournalclub@gmail.com or talk to us on Twitter @AddictionMedJC. If you want to hear your comment in your own voice on the air, you can record a voice memo on your phone and email it to us.
Credits:
- Original theme music composed and performed by Benjamin Kennedy
- Audio production by Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Episode 4 discusses the benefits of smoking cessation after a diagnosis of lung cancer.
Mahdi Sheikh, Anush Mukeriya, Oxana Shangina, et al. Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality: A Prospective Cohort Study. Ann Intern Med.2021;174:1232-1239. [Epub 27 July 2021].
We also talk about whether or not increased buprenorphine prescribing will lead patients to be placed on it inappropriately, and some of the hurdles faced when trying to prescribe medications for opioid use disorder in the hospital.
To make sure you’re prescribing buprenorphine correctly, read SAMHSA’s Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings.
Take a look at the article A Call to Action: Hospitalists' Role in Addressing Substance Use Disorder.
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, you can email us at addictionmedicinejournalclub@gmail.com or talk to us on Twitter @AddictionMedJC. If you want to hear your comment in your own voice on the air, you can record a voice memo on your phone and email it to us.
Credits:
- Original theme music: composed and performed by Benjamin Kennedy
- Audio production: Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
In episode 3 we discuss the risks of tapering for patients on long-term, high-dose opioids.
Article citation: Agnoli, A., Xing, G., Tancredi, D. J., Magnan, E., Jerant, A., & Fenton, J. Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids. JAMA, 326(5), 411–419. August 3, 2021.
We also discuss how to get your DEA waiver to prescribe buprenorphine in just 5 minutes.
If you want to start prescribing buprenorphine right away take a look at the SAMHSA quick-start guide, or the ASAM one-hour mini-course.
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. In this podcast we review current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, you can email us at addictionmedicinejournalclub@gmail.com or talk to us on Twitter @AddictionMedJC. You can also record a voice memo on your phone and email it to us, and we might include your comment in your own voice on the air.
Credits:
- Original theme music composed and performed by Benjamin Kennedy
- Audio production by Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
In episode 2 we discuss the safety of prescribing stimulants for patients receiving buprenorphine.
Article Citation: Mintz CM, Xu KY, Presnall NJ, et al. Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder. JAMA Netw Open. 2022;5(5):e2211634. doi:10.1001/jamanetworkopen.2022.11634
We also discuss marketing of flavored tobacco and nicotine products to children.
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. In this podcast we review current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, you can email us at addictionmedicinejournalclub@gmail.com or talk to us on Twitter @AddictionMedJC. If you want to hear your comment in your own voice on the air, you can record a voice memo on your phone and email it to us.
Credits:
- Original theme music composed and performed by Benjamin Kennedy
- Audio production by Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
1: The Cardiovascular Effects of Alcohol
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. In this podcast we review current articles to help you stay up to date with research that you can use in your addiction medicine practice.
This week we discuss the article “Association of Habitual Alcohol Intake with Risk of Cardiovascular Disease,” a reexamination of the question of how alcohol intake is related to cardiovascular outcomes, and whether or not the J-curve for risks of alcohol intake actually exists.
Article citation: Biddinger KJ, Emdin CA, Haas ME, et al. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease. JAMA Netw Open. 2022;5(3):e223849. doi:10.1001/jamanetworkopen.2022.3849.
We also discuss xylazine as an additive to illicit opioids, and the possible FDA ban on menthol and flavored tobacco products.
Useful links:
NIH fact sheet on Xylazine
The Harm Reduction Coalition
FDA fact sheets on vaping and nicotine products
FDA announcement on banning flavored tobacco products from JUUL
JAMA Guide to Statistics: Mendelian Randomization
The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, you can email us at addictionmedicinejournalclub@gmail.com or talk to us on Twitter @AddictionMedJC. You can also record a voice memo on your phone and email it to us, and we might include your comment in your own voice on the air.
Credits:
Original theme music: composed and performed by Benjamin Kennedy
Audio production: Angela Ohlfest
Addiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.